Quality of Life and Addiction Among Hospital Night Workers (ALADDIN)

Quality of Life and Addiction Among Hospital Night Workers - Descriptive Study of APHP Workers in Paris

The current context of the Covid-19 health crisis leads to an over-solicitation of health systems, with hospital staff in the front line. These personnel are undergoing high levels of stress, an alteration of their life rhythm, but also of their health status and quality of life at work. In addition, night work, through the disruption of circadian rhythms, has consequences on physical and mental health. The more frequent worsening of the condition of certain patients at night increases the burden and responsibilities of night staff. Increasing the use of psychoactive substances (SPAs) can become a solution for managing stress, work rhythms, sleep disorders and their consequences. This self-medication behaviour is not without risks, neither for staff nor for patients.

The ALADDIN study is a project made up of 2 waves of questionnaires - one during and the other after the Covid "hospital" crisis - filled in by the hospital night staff of AP-HP. This project will assess the impact of the Covid-19 epidemic on the quality of work life, mental health disorders, post-traumatic stress and substance use of hospital night staff.

The main objectives of this study is to evaluate the prevalence of psychoactive substance consumption among the night shift healthcare workers of the AP-HP and to describe the participants' quality of working life.

Methods The study is prospective study using an online self-completed questionnaire. The questionnaire was elaborated on the basis of the validated scales ASSIST (Alcohol, Smoking, and Substance Involvement Screening Test), AUDIT-C (Alcohol Use Disorder Test, shortened version) and HAD (for anxiety and depression) and on qualitative interviews conducted among care staff working the night shift.

The questionnaire will be completed at t0 (baseline) and 18 months after. This study will provide data on the consumption psychoactive substances by night hospital workers adn their quality of working life. It will also allow us to compare their consumption with the general population, and to describe the risk factors influencing the consumption.

Study Overview

• Status: Recruiting
• Conditions: Substance-Related Disorders; Quality of Life; Addiction; Health Services Research; Health Personnel

• Study Type: Observational
• Enrollment (Anticipated): 1800

Contacts and Locations

• Study Contact: Name: Lorraine COUSIN, PhDc; Phone Number: 0683586227; Email: cousinlorraine@gmail.comlorraine.cousin-ext@aphp.fr
• Study Contact Backup: Name: Olivia Rousset Torrente, MD; Phone Number: 0140274689; Email: olivia.rousset-torrente-ext@aphp.fr

Study Locations

• France
  • Le Kremlin-Bicêtre, France, 94275
    • Recruiting
    • Hopital de Bicetre
    • Contact: Aïchata F Dara, MD; Phone Number: 33 0140275544; Email: adara.proqol@gmail.com
  • Paris, France, 75004
    • Recruiting
    • Assistance Publique des Hopitaux de Paris
    • Contact: Lorraine COUSIN, PhDc; Phone Number: 0144841777; Email: lorraine.cousin-ext@aphp.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 16 years to 67 years (ADULT, OLDER_ADULT, CHILD)
• Accepts Healthy Volunteers: N/A
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

As night workers are more prone to impaired health and to addictions, the study focuses on hospital night workers who represent a population particularly at risk.

Description

Inclusion Criteria:

- hospital workers at APHP, working at night or night and day alternance (working at least 3 hours between 9 p.m and 6 a.m, 2 times a week)

Exclusion Criteria:

• Hospital workers working during the day
• Workers working less than 3 hours a night two time a week
• Doctors

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Substance use prevalence	Prevalence in APHP health workers of psychoactive substance consumption during the Covid 19 outbreak	at T0 month : baseline
Quality of working life scale	Evaluation of the quality of working life during the Covid 19 outbreak using a validated scale	at T0 month : baseline

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Intervention preference	Identify the preferences for intervention to improve the quality of life or change the addictive risk of night hospital staff at the APHP. Preferences for intervention methods and ranking of the least preferred.	at T0 month
Psychoactive substance consumption and associated factors	Describe the risk factors associated with the consumption of psychoactive substances (PAS). Logistic or fish linear regression depending on the type of variable taken into account.	at T0 month
Impact of substance consumption on quality of life at work	Evaluate the impact of substance use on quality of life at work Principal component analysis and classification to see if there are consumer groups for the night and / or day population. Method for taking into account missing, unused or invalid data	at T0 month
Risk factors associated with tobacco use	Describe the risk factors associated with tobacco use among night hospital workers,	at T0 month
Impact of sleep quality on quality of working life and perceived health	Evaluate the impact of sleep quality on the quality of working life and perceived health of night staff	at T0 month
Impact of anxiety and depressive symptoms on sleep and QWL.	Describe the links between QWL and sleep, anxiety, depressive syndromes, and workplace upheaval.	at T0 month
Impact of sleep and workplace upheaval on anxiety and depressives symptoms	Describe the links between anxiety/depressive syndromes and workplace disruption, sleep, and the Covid epidemic.	at T month
Modification of quality of working life score and psychoactive substances consumption prevalences	Comparison between the baseline score and prevalences and the score and prevalences 18 months after	T18 months
Comparison of modification of quality of life score and declared quality of life modification after 18 month	Analysis of the relation between declared change and evolution of the quality of life score	T18 months

Collaborators and Investigators

• Sponsor: University Paris 7 - Denis Diderot
• Collaborators: Assistance Publique - Hôpitaux de Paris; Institut National de la Santé Et de la Recherche Médicale, France

Study record dates

Study Major Dates

• Study Start (ACTUAL): June 15, 2020
• Primary Completion (ANTICIPATED): April 1, 2022
• Study Completion (ANTICIPATED): June 1, 2023

Study Registration Dates

• First Submitted: February 4, 2020
• First Submitted That Met QC Criteria: February 27, 2020
• First Posted (ACTUAL): March 2, 2020

Study Record Updates

• Last Update Posted (ACTUAL): November 4, 2020
• Last Update Submitted That Met QC Criteria: November 2, 2020
• Last Verified: November 1, 2020

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Chemically-Induced Disorders; Compulsive Behavior; Impulsive Behavior; Substance-Related Disorders; Behavior, Addictive
• Other Study ID Numbers: ALADDIN-QoLHospWork

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No